Recombinant multi-species KAP1/TRIM28 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KAP1/TRIM28 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene mediates transcriptional control by interaction with the Kruppel-associated box repression domain found in many transcription factors. The protein localizes to the nucleus and is thought to associate with specific chromatin regions. The protein is a member of the tripartite motif family. This tripartite motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. [provided by RefSeq, Jul 2008]
The Alternative Names of target: E3 SUMO-protein ligase TRIM28,KAP-1,KAP1,KRAB-associated protein 1 (KAP-1),KRAB-interacting protein 1 (KRIP-1),KRIP-1,Kap1,Krip1,MommeD9,Nuclear corepressor KAP-1,PPP1R157,RING finger protein 96,RING-type E3 ubiquitin transferase TIF1-beta,RNF96,TF1B,TIF1-beta,TIF1B,TIF1BETA,TIF1beta,TRIM28,Tif1b,Tif1beta,Transcription intermediary factor 1-beta,Trim28,Tripartite motif-containing protein 28

Target products collectionGo to KAP1/TRIM28 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T91624-Ag-1/ GM-Tg-hg-T91624-Ag-2 Human KAP1/TRIM28 protein Human
GM-Tg-rg-T91624-Ag-1/ GM-Tg-rg-T91624-Ag-2 Rat KAP1/TRIM28 protein Rat
GM-Tg-mg-T91624-Ag-1/ GM-Tg-mg-T91624-Ag-2 Mouse KAP1/TRIM28 protein Mouse
GM-Tg-cynog-T91624-Ag-1/ GM-Tg-cynog-T91624-Ag-2 Cynomolgus/Rhesus macaque KAP1/TRIM28 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T91624-Ag-1/ GM-Tg-felg-T91624-Ag-2 Feline KAP1/TRIM28 protein Feline
GM-Tg-cang-T91624-Ag-1/ GM-Tg-cang-T91624-Ag-2 Canine KAP1/TRIM28 protein Canine
GM-Tg-bovg-T91624-Ag-1/ GM-Tg-bovg-T91624-Ag-2 Bovine KAP1/TRIM28 protein Bovine
GM-Tg-equg-T91624-Ag-1/ GM-Tg-equg-T91624-Ag-2 Equine KAP1/TRIM28 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T91624-Ag-1/ GM-Tg-hg-T91624-Ag-2; GM-Tg-rg-T91624-Ag-1/ GM-Tg-rg-T91624-Ag-2;
GM-Tg-mg-T91624-Ag-1/ GM-Tg-mg-T91624-Ag-2; GM-Tg-cynog-T91624-Ag-1/ GM-Tg-cynog-T91624-Ag-2;
GM-Tg-felg-T91624-Ag-1/ GM-Tg-felg-T91624-Ag-2; GM-Tg-cang-T91624-Ag-1/ GM-Tg-cang-T91624-Ag-2;
GM-Tg-bovg-T91624-Ag-1/ GM-Tg-bovg-T91624-Ag-2; GM-Tg-equg-T91624-Ag-1/ GM-Tg-equg-T91624-Ag-2
Products Name KAP1/TRIM28 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name KAP1/TRIM28
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KAP1/TRIM28 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.